MTI013 is a selective SARS-CoV-2 nsp14 Mtase inhibitor (IC50: 2.98 µM) and an antiviral agent (IC50: 10.33 µM in HCoV-229E-infected Huh7 cells). MTI013 also shows a synergistic antiviral effect with the RdRp inhibitor SHEN26 (HY-155488)[1].
Molecular Weight:
492.55
Formula:
C24H24N6O4S
Target:
SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
